It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Human serum albumin (HSA) is the most abundant serum protein, contributing to the maintenance of redox balance in the extracellular fluids. One single free cysteine residue at position 34 is believed to be a target of oxidation. However, the molecular details and functions of oxidized HSAs remain obscure. Here we analyzed serum samples from normal subjects and hyperlipidemia patients and observed an enhanced S-thiolation of HSA in the hyperlipidemia patients as compared to the control individuals. Both cysteine and homocysteine were identified as the low molecular weight thiols bound to the HSAs. Intriguingly, S-thiolations were observed not only at Cys34, but also at multiple cysteine residues in the disulfide bonds of HSA. When the serum albumins from genetically modified mice that exhibit high levels of total homocysteine in serum were analyzed, we observed an enhanced S-homocysteinylation at multiple cysteine residues. In addition, the cysteine residues in the disulfide bonds were also thiolated in recombinant HSA that had been treated with the disulfide molecules. These findings and the result that S-homocysteinylation mediated increased surface hydrophobicity and ligand binding activity of HSA offer new insights into structural and functional alternation of serum albumins via S-thiolation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan
2 Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan; PRESTO, Japan Science and Technology Agency (JST), Kawaguchi, Saitama, Japan
3 Institute for Innovation for Future Society, Nagoya University, Nagoya, Japan
4 Department of Medical Technique, Nagoya University Hospital, Nagoya, Japan
5 Department of Clinical Laboratory and Blood Transfusion, Nagoya University Hospital, Nagoya, Japan
6 Department of Health Chemistry, Showa Pharmaceutical University, Tokyo, Japan
7 Department of Pharmacology and Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical School, Nashville, Tennessee, USA
8 Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan; Institute for Innovation for Future Society, Nagoya University, Nagoya, Japan; Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan